Trial Outcomes & Findings for Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear (NCT NCT00584220)

NCT ID: NCT00584220

Last Updated: 2015-05-21

Results Overview

A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score \>0 then greater vision, if \<0 then lesser vision.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

96 participants

Primary outcome timeframe

1 week

Results posted on

2015-05-21

Participant Flow

Of those 96 enrolled subjects in the study, 7 did not meet the study eligibility criteria and 1 did not receive the study lenses. One enrolled subject was discontinued from the study leaving n=87 who completed the study.

Participant milestones

Participant milestones
Measure
Senofilcon A / Alphafilcon A
senofilcon A toric silicone hydrogel contact lenses worn first, then alphafilcon A toric hydrogel contact lenses worn second
Alphafilcon A / Senofilcon A
alphafilcon A toric hydrogel contact lenses worn first, then senofilcon A toric silicone hydrogel contact lenses worn second
First Period
STARTED
48
39
First Period
COMPLETED
48
39
First Period
NOT COMPLETED
0
0
Second Period
STARTED
48
39
Second Period
COMPLETED
48
39
Second Period
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Subjects
n=87 Participants
Subjects who enrolled and completed the study.
Age, Continuous
28.0 years
STANDARD_DEVIATION 5.98 • n=5 Participants
Sex: Female, Male
Female
51 Participants
n=5 Participants
Sex: Female, Male
Male
36 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 week

Population: Analysis includes only participants who completed the study per protocol and had no missing data.

A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score \>0 then greater vision, if \<0 then lesser vision.

Outcome measures

Outcome measures
Measure
Senofilcon A Toric
n=87 Participants
contact lenses
Alphafilcon A Toric
n=87 Participants
contact lenses
Subjective Reported Vision
0.33 Units on a scale
Standard Deviation 0.795
-0.17 Units on a scale
Standard Deviation 0.788

PRIMARY outcome

Timeframe: 1 week

Population: Analysis includes only participants who completed the study per protocol and had no missing data.

A weighted combined score of one week and two week data calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the estimates for senofilcon A and alphafilcon A, respectively. Interpretation is \>0 indicates comfortable and \<0 indicates uncomfortable.

Outcome measures

Outcome measures
Measure
Senofilcon A Toric
n=87 Participants
contact lenses
Alphafilcon A Toric
n=87 Participants
contact lenses
Subject Reported Lens Comfort.
0.37 Units on a scale
Standard Deviation 0.730
-0.38 Units on a scale
Standard Deviation 0.723

Adverse Events

Senofilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Alphafilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kurt Moody, OD, FAAO

Vistakon

Phone: 904-443-3088

Results disclosure agreements

  • Principal investigator is a sponsor employee The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
  • Publication restrictions are in place

Restriction type: OTHER